Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules

Faizal Z. Asumda, Konstantinos E. Hatzistergos, Derek M Dykxhoorn, Silvia Jakubski, Jasmine Edwards, Emmanuel Thomas, Eugene R Schiff

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A variety of approaches have been developed for the derivation of hepatocyte-like cells from pluripotent stem cells. Currently, most of these strategies employ step-wise differentiation approaches with recombinant growth-factors or small-molecule analogs to recapitulate developmental signaling pathways. Here, we tested the efficacy of a small-molecule based differentiation protocol for the generation of hepatocyte-like cells from human pluripotent stem cells. Quantitative gene-expression, immunohistochemical, and western blot analyses for SOX17, FOXA2, CXCR4, HNF4A, AFP, indicated the stage-specific differentiation into definitive endoderm, hepatoblast and hepatocyte-like derivatives. Furthermore, hepatocyte-like cells displayed morphological and functional features characteristic of primary hepatocytes, as indicated by the production of ALB (albumin) and α-1-antitrypsin (A1AT), as well as glycogen storage capacity by periodic acid-Schiff staining. Together, these data support that the small-molecule based hepatic differentiation protocol is a simple, reproducible, and inexpensive method to efficiently drive the differentiation of human pluripotent stem cells towards a hepatocyte-like phenotype, for downstream pharmacogenomic and regenerative medicine applications.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalDifferentiation
Volume101
DOIs
StatePublished - May 1 2018

Fingerprint

Pluripotent Stem Cells
Hepatocytes
Endoderm
Periodic Acid
Regenerative Medicine
Pharmacogenetics
Glycogen
Albumins
Intercellular Signaling Peptides and Proteins
Western Blotting
Staining and Labeling
Phenotype
Gene Expression
Liver

Keywords

  • Hepatocyte
  • Hepatocyte-like cells
  • Human pluripotent stem cell differentiation
  • Small molecules

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Biology
  • Cell Biology
  • Cancer Research

Cite this

Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules. / Asumda, Faizal Z.; Hatzistergos, Konstantinos E.; Dykxhoorn, Derek M; Jakubski, Silvia; Edwards, Jasmine; Thomas, Emmanuel; Schiff, Eugene R.

In: Differentiation, Vol. 101, 01.05.2018, p. 16-24.

Research output: Contribution to journalArticle

Asumda, Faizal Z. ; Hatzistergos, Konstantinos E. ; Dykxhoorn, Derek M ; Jakubski, Silvia ; Edwards, Jasmine ; Thomas, Emmanuel ; Schiff, Eugene R. / Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules. In: Differentiation. 2018 ; Vol. 101. pp. 16-24.
@article{d8e3ed722551457eb7b15e505fc3c8a7,
title = "Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules",
abstract = "A variety of approaches have been developed for the derivation of hepatocyte-like cells from pluripotent stem cells. Currently, most of these strategies employ step-wise differentiation approaches with recombinant growth-factors or small-molecule analogs to recapitulate developmental signaling pathways. Here, we tested the efficacy of a small-molecule based differentiation protocol for the generation of hepatocyte-like cells from human pluripotent stem cells. Quantitative gene-expression, immunohistochemical, and western blot analyses for SOX17, FOXA2, CXCR4, HNF4A, AFP, indicated the stage-specific differentiation into definitive endoderm, hepatoblast and hepatocyte-like derivatives. Furthermore, hepatocyte-like cells displayed morphological and functional features characteristic of primary hepatocytes, as indicated by the production of ALB (albumin) and α-1-antitrypsin (A1AT), as well as glycogen storage capacity by periodic acid-Schiff staining. Together, these data support that the small-molecule based hepatic differentiation protocol is a simple, reproducible, and inexpensive method to efficiently drive the differentiation of human pluripotent stem cells towards a hepatocyte-like phenotype, for downstream pharmacogenomic and regenerative medicine applications.",
keywords = "Hepatocyte, Hepatocyte-like cells, Human pluripotent stem cell differentiation, Small molecules",
author = "Asumda, {Faizal Z.} and Hatzistergos, {Konstantinos E.} and Dykxhoorn, {Derek M} and Silvia Jakubski and Jasmine Edwards and Emmanuel Thomas and Schiff, {Eugene R}",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.diff.2018.03.002",
language = "English (US)",
volume = "101",
pages = "16--24",
journal = "Differentiation",
issn = "0301-4681",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules

AU - Asumda, Faizal Z.

AU - Hatzistergos, Konstantinos E.

AU - Dykxhoorn, Derek M

AU - Jakubski, Silvia

AU - Edwards, Jasmine

AU - Thomas, Emmanuel

AU - Schiff, Eugene R

PY - 2018/5/1

Y1 - 2018/5/1

N2 - A variety of approaches have been developed for the derivation of hepatocyte-like cells from pluripotent stem cells. Currently, most of these strategies employ step-wise differentiation approaches with recombinant growth-factors or small-molecule analogs to recapitulate developmental signaling pathways. Here, we tested the efficacy of a small-molecule based differentiation protocol for the generation of hepatocyte-like cells from human pluripotent stem cells. Quantitative gene-expression, immunohistochemical, and western blot analyses for SOX17, FOXA2, CXCR4, HNF4A, AFP, indicated the stage-specific differentiation into definitive endoderm, hepatoblast and hepatocyte-like derivatives. Furthermore, hepatocyte-like cells displayed morphological and functional features characteristic of primary hepatocytes, as indicated by the production of ALB (albumin) and α-1-antitrypsin (A1AT), as well as glycogen storage capacity by periodic acid-Schiff staining. Together, these data support that the small-molecule based hepatic differentiation protocol is a simple, reproducible, and inexpensive method to efficiently drive the differentiation of human pluripotent stem cells towards a hepatocyte-like phenotype, for downstream pharmacogenomic and regenerative medicine applications.

AB - A variety of approaches have been developed for the derivation of hepatocyte-like cells from pluripotent stem cells. Currently, most of these strategies employ step-wise differentiation approaches with recombinant growth-factors or small-molecule analogs to recapitulate developmental signaling pathways. Here, we tested the efficacy of a small-molecule based differentiation protocol for the generation of hepatocyte-like cells from human pluripotent stem cells. Quantitative gene-expression, immunohistochemical, and western blot analyses for SOX17, FOXA2, CXCR4, HNF4A, AFP, indicated the stage-specific differentiation into definitive endoderm, hepatoblast and hepatocyte-like derivatives. Furthermore, hepatocyte-like cells displayed morphological and functional features characteristic of primary hepatocytes, as indicated by the production of ALB (albumin) and α-1-antitrypsin (A1AT), as well as glycogen storage capacity by periodic acid-Schiff staining. Together, these data support that the small-molecule based hepatic differentiation protocol is a simple, reproducible, and inexpensive method to efficiently drive the differentiation of human pluripotent stem cells towards a hepatocyte-like phenotype, for downstream pharmacogenomic and regenerative medicine applications.

KW - Hepatocyte

KW - Hepatocyte-like cells

KW - Human pluripotent stem cell differentiation

KW - Small molecules

UR - http://www.scopus.com/inward/record.url?scp=85044964852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044964852&partnerID=8YFLogxK

U2 - 10.1016/j.diff.2018.03.002

DO - 10.1016/j.diff.2018.03.002

M3 - Article

C2 - 29626713

AN - SCOPUS:85044964852

VL - 101

SP - 16

EP - 24

JO - Differentiation

JF - Differentiation

SN - 0301-4681

ER -